Todd Lopeman

Mr. Lopeman joined Dynavax in 2014 and currently serves as Vice President Technical Operations. Mr. Lopeman is a key member of the leadership team responsible for technical leadership and strategy for both owned and external contract manufacturing organizations, process development, engineering, manufacturing sciences teams and information technology to support the launch of HEPLISAV-B. Mr. Lopeman has over 25 years experience in all aspects of process engineering including new facility design, existing facility upgrades and ensuring overall engineering compliance with regulatory requirements. Mr. Lopeman has held positions of increasing responsibilities with Novartis, Sandoz/Novartis, and KMI/Parexel in the U.S. and internationally. Mr. Lopeman earned a B.S. in Chemical Engineering from North Carolina State University, Raleigh.